Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down – Time to Sell?

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG)’s share price gapped down before the market opened on Monday. The stock had previously closed at $14.88, but opened at $14.23. Ascentage Pharma Group International shares last traded at $14.07, with a volume of 429 shares changing hands.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on AAPG shares. Citigroup started coverage on shares of Ascentage Pharma Group International in a research note on Wednesday, October 14th. They issued a “buy” rating and a $46.00 price objective for the company. William Blair initiated coverage on shares of Ascentage Pharma Group International in a report on Friday, October 16th. They set an “outperform” rating for the company. BTIG Research reiterated a “buy” rating and issued a $48.00 price target on shares of Ascentage Pharma Group International in a research note on Friday, August 21st. Citizens Jmp initiated coverage on Ascentage Pharma Group International in a report on Tuesday, October 13th. They set a “market outperform” rating and a $35.00 price objective on the stock. Finally, JPMorgan Chase & Co. reduced their price objective on Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company. According to data from MarketBeat, Ascentage Pharma Group International has an average rating of “Buy” and a consensus price target of $43.90.

Ascentage Pharma Group International Trading Down 0.8%

The business’s fifty day moving average price is $15.72 and its 200 day moving average price is $20.06. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.18 and a current ratio of 1.22.

Ascentage Pharma Group International (NASDAQ:AAPG) last issued its quarterly earnings data on Wednesday, August 19th. The company reported ($0.65) earnings per share for the quarter. The company had revenue of $22.24 million for the quarter. Equities analysts anticipate that Ascentage Pharma Group International – Unsponsored ADR will post -2.43 earnings per share for the current year.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.